TrialRheumatology international2016

Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis.

William G Reiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.